A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherapy for High-Grade Appendiceal and Colorectal Adenocarcinoma With Peritoneal Metastasis

Abroad (travel likely)Recruiting

Conditions

Appendiceal Cancer · Colorectal Adenocarcinoma · Peritoneal Metastases

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Yale New Haven Hospital, New Haven, Connecticut, United States

Study leads

Kiran Turaga, MD
Principal Investigator
Yale University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies

Peritoneal Mesothelioma · Peritoneal Carcinomatosis · Ovarian Cancer

Abroad (travel likely)RecruitingPHASE1

Bethesda, United States

Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)

Small Bowel Cancer · Colorectal Cancer · Appendiceal Cancer

Abroad (travel likely)Recruiting

Sacramento, United States

Molecular Profiling for Risk Stratification in Appendiceal Cancer

Appendiceal Cancer · Appendiceal Adenocarcinoma

Abroad (travel likely)Recruiting

Durate, United States

A Prospective Feasibility Study Using ctDNA to Tailor Neoadjuvant Chemotherapy for Patients With Colorectal or Appendiceal Adenocarcinoma

Appendiceal Adenocarcinoma · Colorectal

Abroad (travel likely)Recruiting

Houston, United States